FORM N-PX PROXY VOTING RECORD

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 COLUMN 9 COLUMN 10 COLUMN 11 COLUMN 12 COLUMN 13 COLUMN 14 COLUMN 15
NAME   OF   ISSUER
 CUSIP ISIN FIGI MEETING   DATE VOTE   DESCRIPTION VOTE   CATEGORY DESCRIPTION   OF   OTHER  CATEGORY VOTE   SOURCE SHARES   VOTED SHARES   ON   LOAN DETAILS   OF   VOTE MANAGER   NUMBER SERIES   ID OTHER   INFO
HOW   VOTED SHARES  VOTED FOR   OR   AGAINST   MANAGEMENT
Arrowhead Pharmaceuticals 04280A100 - - 3/14/2024 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Senseonics Holdings, Inc. 81727U105 - - 5/22/2024 Advisory approval of the compensation of the Company?s named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Procept BioRobotics Corporation 74276L105 - - 6/04/2024 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Aldeyra Therapeutics, Inc. 01438T106 - - 6/04/2024 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Adicet Bio, Inc. 007002108 - - 6/5/2024 To ratify, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Adicet Bio, Inc. 007002108 - - 6/5/2024 To ratify, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Marker Therapeutics, Inc. 57055L206 - - 6/6/2024 To approve, on an advisory basis, the compensation of the Company?s named executive officers, as disclosed in this proxy statement SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Xencor, Inc. 98401F105 - - 6/13/2024 To approve,by non-binding advisory vote, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Altimmune Inc 02155H200 - - 9/28/2023 Balloting on Proposal 3, to approve, on an advisory basis, the compensation of the Company?s named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Altimmune Inc 02155H200 - - 9/28/2023 Balloting on Proposal 4, to approve, on an advisory basis, on the frequency of future advisory votes on the compensation of the Company?s named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Gyre Therapeutics, Inc. 403783103 - - 8/29/2023 To approve, by non-binding advisory vote, the compensation of Catalyst?s named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Gyre Therapeutics, Inc. 403783103 - - 8/29/2023 To conduct an advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Standard Biotools, Inc. 34385P108 - - 6/27/2024 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0 0 ABSTAIN
 0
 NONE
 - -
Meira GTx Holdings plc G59665102 - - 6/6/2024 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 6641064 0 FOR
 6641064
 FOR
 - -
Meira GTx Holdings plc G59665102 - - 6/6/2024 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 6641064 0 1YEAR
 6641064
 AGAINST
- -
Fate Therapeutics, Inc. 31189P102 - - 6/7/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 3379064 0 FOR
 3379064
 FOR
 - -
Protagonist Therapeutics Inc. 74366E102 - - 6/20/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2449183 0 FOR
 2449183
 FOR
 - -

[Repeat as Necessary]